reSee.it - Related Video Feed

The episode centers on emerging science for protecting brain health and reducing risk of cognitive decline, with Louisa Nicola explaining that higher daily creatine intake—10 to 20 grams rather than the traditional five grams—may more effectively feed brain energy and support cognitive functions such as processing speed, memory, attention, and recall. She notes a German cohort study showing five grams saturates muscle but not brain energy, whereas 15–20 grams may enhance brain metabolism, potentially aiding those at risk of mild cognitive impairment, Alzheimer’s disease, or prior brain injury. The discussion covers practical dosing approaches, potential gastrointestinal side effects, and how to distribute intake across the day, including mixing with beverages. The conversation also touches caveats around variability in individual health histories, such as stroke, and emphasizes that while no cure exists for dementia, increasing brain energy could help preserve function and daily independence. In addition to creatine, the guests debate complementary brain-health strategies, highlighting vitamin D’s potential to reduce dementia risk in large observational cohorts, especially when levels are deficient, and the need to consider absorption, co-factors like magnesium and K2, and environmental lead. Omega-3 fatty acids, particularly DHA, are praised for improving membrane fluidity, reducing neuroinflammation, supporting myelination, and potentially extending healthy brain function, with tests like the omega-3 index used to gauge risk reduction. The hosts discuss the role of exercise in vascular and brain health, presenting evidence that high-intensity, lower-body training can reverse age-related cardiac decline and bolster brain mass and cognition through myokine signaling and improved blood flow. They also examine lifestyle factors that influence brain inflammation, such as air pollution, indoor air quality, and oxidative stress, underscoring how vascular health and blood flow to the brain are foundational to cognitive resilience. Throughout, the conversation anchors recommendations in energy metabolism and endothelial function, while stressing that beyond essential basics, careful, evidence-based experimentation should be balanced with proven strategies like regular exercise, adequate sleep, nutrient sufficiency, and strong social connections.

Alzheimer's is a growing health crisis, with cases expected to triple by 2030. Currently, individuals reaching age 85 face a 50% chance of diagnosis. Recent revelations have shown that a pivotal 2006 paper supporting the amyloid hypothesis—linking amyloid beta plaques to Alzheimer's—was based on fraudulent data, undermining nearly a century of research focused on pharmaceutical cures. While amyloid plaques are present in many older adults without cognitive deficits, alternative theories, such as the metabolic origin theory, suggest Alzheimer's may stem from glucose hypometabolism in the brain. Despite the amyloid hypothesis directing funding and research, drug trials have largely failed, with a 99.6% failure rate. Controversial drugs like aducanumab, which reduce plaque but do not improve cognition, have raised ethical concerns. The discussion also highlights the overlap between Alzheimer's and other neurodegenerative diseases, emphasizing the importance of neuroinflammation and oxidative stress. The conversation shifts to the role of lifestyle factors in preventing Alzheimer's, with modifiable risk factors including diet, exercise, and social connections. Acknowledgment of the potential for prevention has grown, with studies indicating that up to 40% of dementia cases may be preventable. The hosts stress the need for a holistic approach to brain health, advocating for dietary and lifestyle changes to mitigate risks associated with Alzheimer's and other cognitive decline.

Dr. Rudy Tanzi, a leading researcher in Alzheimer's disease at Mass General Hospital and Harvard Medical School, discusses his extensive work on the disease, including the discovery of the first Alzheimer's gene, amyloid precursor protein. He emphasizes the importance of prevention, noting that amyloid plaques accumulate decades before symptoms appear, similar to cholesterol in heart disease. Tanzi advocates for early detection and intervention, likening amyloid to a match that ignites a fire of neuroinflammation, which ultimately leads to nerve cell death. He highlights the role of microbes in triggering amyloid formation and the potential for primary prevention through vaccines against these pathogens. Tanzi also discusses the innovative "Alzheimer's in a dish" model, which allows for rapid drug screening and has led to promising developments in treatment. He mentions the significance of lifestyle factors in reducing Alzheimer's risk, encapsulated in his "SHIELD" acronym: Sleep, Handle stress, Interact with others, Exercise, Learn new things, and Diet. Tanzi notes the discovery of multiple genes associated with Alzheimer's, emphasizing that while APOE4 is well-known, many others contribute to risk. He is optimistic about upcoming clinical trials for new drugs targeting neuroinflammation and the potential for lifestyle interventions to improve brain health. His work aims to quantify brain health and promote preventative measures, underscoring the need for a holistic approach to combating neurodegenerative diseases.

Dale Bredesen and Richard Johnson discuss the evolving understanding of Alzheimer's disease, emphasizing that for the current generation, particularly those in their 30s to 70s without symptoms, developing Alzheimer's may become optional. Advances in testing and knowledge allow for early detection and intervention, making it possible to prevent cognitive decline. Bredesen highlights that individuals in their 40s and older should engage in active prevention, including evaluations through blood tests to assess risk factors. Bredesen's clinical trial involved participants aged 55 to 75 with mild cognitive impairment (MCI) or early dementia, revealing that 84% showed improvement, contrasting with traditional drug trials that only slow decline. He criticizes the conventional medical model for focusing on singular causes and treatments, advocating for a more holistic approach that considers multiple factors contributing to neurodegenerative diseases. The conversation addresses the complexity of Alzheimer's, likening the brain's network to a country needing balance to function optimally. Factors such as toxins, inflammation, and energy supply are crucial in understanding cognitive decline. Bredesen explains that Alzheimer's is not solely about amyloid plaques but involves a range of contributors, including immune system activation and metabolic health. Bredesen emphasizes the importance of lifestyle changes, including diet, exercise, sleep, stress management, brain training, detoxification, and targeted supplements, which he refers to as the "seven basics." He advocates for a plant-rich, mildly ketogenic diet and regular physical activity to enhance cognitive health. For those diagnosed with cognitive decline, Bredesen recommends getting a cognoscopy to assess brain health and identify specific risk factors. He encourages proactive measures to improve metabolic flexibility and overall well-being. The discussion concludes with a hopeful message that many individuals can avoid Alzheimer's through early intervention and lifestyle modifications, reinforcing the idea that false hopelessness should not deter people from seeking help and making changes.

Alzheimer's disease typically takes about 20 years from the onset of pathophysiology to diagnosis. Cognitive improvement is possible at any age by addressing underlying causes, such as unrecognized toxins or pathogens. Notably, nocturnal oxygen desaturation is critical; studies show that low oxygen levels during sleep correlate with brain volume loss. Many people are unaware of their declining oxygen saturation due to conditions like sleep apnea, which can starve the brain. As the aging population grows, cognitive decline has become a primary concern, surpassing cancer. Currently, around 5.6 million Americans have an Alzheimer's diagnosis, but projections suggest that 45 million could eventually die from the disease. Factors like obesity, poor immunity, and low vitamin D levels increase risks for both Alzheimer's and COVID-19. The complexity of Alzheimer's means it cannot be attributed to a single cause. Early lifestyle factors in younger individuals can increase future risk. The disease is often linked to inflammation, toxins, and hormonal deficiencies. For instance, insulin resistance contributes to cognitive decline through inflammation and reduced trophic support. Addressing these factors early can prevent or reverse symptoms. Dale Bredesen emphasizes the importance of personalized approaches to treatment, identifying root causes, and creating targeted interventions. His research indicates that multiple contributors, including toxins from mold and environmental factors, must be addressed for effective treatment. The Bredesen protocol encourages individuals over 45 to undergo a "cognoscopy" to assess cognitive health proactively. Success stories illustrate that individuals can improve their cognitive function by following a comprehensive protocol that includes lifestyle changes, dietary adjustments, and addressing environmental toxins. The narrative of patients like Deborah, who recognized early signs of cognitive decline and sought intervention, highlights the importance of early detection and personalized care. The overarching message is that Alzheimer's can be an optional disease with appropriate preventive measures and lifestyle adjustments.

The episode centers on nicotinamide adenine dinucleotide, or NAD, a cellular coenzyme that drives energy production and the body’s ability to repair damage. The guest explains how NAD sits at every step of converting nutrients and oxygen into ATP, and how boosting NAD—primarily through the precursors NR—can enhance mitochondrial biogenesis and energy yield without extra calories. They discuss how NAD responds to stressors like poor sleep and overexertion, and how higher NAD levels may support cellular resilience, energy, and healthspan, with potential implications for aging. The conversation emphasizes that NAD dynamics vary across cells and tissues, making it an imperfect stand-alone marker of biological age, yet a meaningful contributor to cellular vitality and repair mechanisms such as PARP enzymes and apoptosis. The dialogue delves into how age-related NAD decline appears in rare genetic disorders and how restoring NAD could help cells cope with metabolic stress, potentially delaying the functional consequences of aging rather than simply extending lifespan. The guests highlight extensive animal research linking NAD to multiple aging-related conditions and reference early human studies, including Parkinson’s and neuroinflammation, noting safety and dose considerations while stressing the need for careful interpretation of results. Finally, they address the practical realities of supplementation, warning against NAD infusions and endorsing NR-based approaches paired with thoughtful self-tracking to gauge meaningful improvements in recovery, sleep, and energy over several months. A broader arc of the episode is a critical look at how new nutritional science is translated into consumer products and public understanding. The guest describes a landscape where hype and misinformation can outpace rigorous evidence, especially in a market flooded with so-called NAD boosters and IV therapies. They discuss the challenges of measuring NAD levels in tissues, the difference between blood NAD and tissue NAD, and the importance of preferring well-characterized precursors that can actually enter cells. The conversation also touches on the commercial and regulatory dynamics of the supplement industry, the emergence of professional standards like independent certifications, and the idea of industry alliances to promote transparency. The host and guest reflect on the ethics of biohacking, the line between science and sensationalism, and the responsibility to educate listeners who are navigating a complex wellness space while aspiring to healthier, longer lives.

Dr. Jack Feldman, a pioneer in respiration research, explained the mechanics and neural control of breathing. He detailed how the diaphragm and rib cage facilitate air exchange, driven by the pre-Bötzinger complex for inspiration and a separate oscillator for active expiration. Feldman emphasized the mammalian diaphragm's evolutionary advantage, enabling efficient oxygen uptake through a vast alveolar surface area, critical for supporting large brains. He also discussed physiological sighs, involuntary deep breaths occurring every few minutes to prevent alveolar collapse, a vital mechanism for lung health and mechanical ventilation. The podcast then explored breathing's profound impact on brain states and emotional regulation. Rodent studies showed that deliberate slow breathing significantly reduces fear responses, demonstrating a mechanistic effect on neural circuits. This influence operates via olfactory signals, vagus nerve activity (linked to depression relief), and carbon dioxide levels, which affect brain pH and can induce anxiety. Volitional breathing also sends descending commands that modulate emotional states. Feldman suggested breathing practices can disrupt and weaken maladaptive neural circuits, promoting healthier brain function. He personally recommends short, consistent box breathing for improved performance and well-being. Finally, the discussion covered magnesium L-threonate, a supplement discovered to enhance long-term potentiation (neuroplasticity) and cognitive function. Human studies revealed it improved cognitive age by an average of eight years in individuals with mild cognitive decline and also aids sleep. Feldman underscored the value of mechanistic studies, even in rodents, to understand the efficacy and optimal application of these practices and supplements, moving beyond anecdotal evidence.

Dr. Fotuhi outlines a framework for cognitive longevity centered on five pillars: fitness, optimal sleep, brain-healthy nutrition, mindset, and brain training. He describes a progression of cognitive decline beginning with age-associated memory impairment, moving to mild cognitive impairment, and then to Alzheimer’s dementia, emphasizing that many memory lapses are reversible and often caused by modifiable factors such as sleep deficits, stress, nutrition, hearing or vision loss, and environmental influences like air pollution. The discussion highlights how the hippocampus, a critical structure for learning and memory, shrinks when deprived of stimulation or when challenged by chronic stress and sensory deficits, and how early-stage declines can be mitigated through comprehensive lifestyle changes rather than medication alone. A key theme is that Alzheimer’s disease is a spectrum with reversible elements in the early stages, and that multidisciplinary lifestyle interventions can reduce amyloid and tau pathology, sometimes reversing measurable cognitive decline. The speaker details clinical observations from programs that combine brain training, diet, social engagement, exercise, and medical optimization, noting reported improvements in memory tasks and real-world functioning. He emphasizes that progress is achievable in a structured 12-week or longer program, especially when medical issues such as sleep apnea, vitamin deficiencies, thyroid problems, and metabolic health are simultaneously addressed to provide the brain with energy and resilience. The conversation also covers practical aspects of implementing the five pillars: setting realistic goals, gradual habit formation, and exploiting synergies between pillars (for example, dancing or hiking that blends physical activity, cognitive challenge, and social interaction). Towards the end, Fotuhi discusses the broader implications of purpose and mindset, explaining that a strong sense of purpose can biologically buffer cognitive decline, and he reinforces the idea of treating brain health as a long-term, sustainable investment rather than a stressful be-all-end-all project. He closes with a humane reminder to pursue happiness today while maintaining a healthy brain for the long horizon of life, advocating a garden-like view where small, consistent actions accumulate into meaningful cognitive benefits.

Recent revelations in Alzheimer's research highlight that a 2006 paper published in Nature contained fraudulent data, significantly impacting the field and misallocating funding. The amyloid hypothesis, which posited that amyloid plaques cause Alzheimer's, has been challenged as studies show no correlation between plaque levels and cognitive decline. The fraudulent study claimed to identify a harmful amyloid subtype, leading to renewed funding and support for the hypothesis. Additionally, a recent meta-analysis debunks the serotonin deficiency theory of depression, indicating no evidence of lower serotonin levels in depressed individuals. This underscores the complexity of both conditions and the need for alternative research avenues.